breast-cancer-congress-2017-scientifictracks

13 / 22

Page 42
Notes:
conferenceseries .com
6th World Congress on
October 16-18, 2017 | San Francisco, USA
Breast Cancer & Therapy
Volume 2, Issue 5 (Suppl) Breast Can Curr Res, an open access journal Breast Cancer Congress 2017
October 16-18, 2017
A randomised controlled trial of the efficacy of a controlled compression garment versus compressive
bandaging in the immediate postoperative period after breast cancer - conserving surgery
Carmen Delgado Jiménez
Universitary Valme Hospital, Spain
Objectives: To compare the overall and individual incidence of postoperative complications, comfort and quality of life resulting
from the use of compressive bandaging versus a specific controlled compression garment.
Patients and Method: A multicentric randomised controlled trial was conducted in 198 patients distributed in 2 groups: bandaging
(n = 88) and compression garment (n = 99). Variables related to immediate postoperative complications and satisfaction with quality
of life were collected. Changes in the variables were compared in the 2 groups during the first postoperative month. Results: The
incidence of total complications was significantly lower with the compression
Garment: 7 days (p = 0.032) and 15 days (p = 0.009). Pain was significantly reduced with the
Compression Garment: 7 days (p = 0.002) and 15 days (p = 0.012). The incidence of skin injury was also significantly reduced: 0-2%
with the compression garment versus 35% with bandaging (p < 0.0005). Significant differences were found in quality of life in favour
of the use of the compression garment (p < 0.0005).
Conclusions: The use of a specific controlled compression garment in the immediate postoperative period after breast cancer-
conserving surgery reduces the likelihood of postoperative complications from 32% to 15% and enhanced efficacy, safety, and patient
comfort compared with the usual compressive dressing
Biography
Carmen Delgado has completed her PhD at the age of 24 years in Seville University (Spain) and postdoctoral studies at the age of 29 years also in Seville University School
of Medicine. Master in Breast Pathology. She is the director of Breast Cancer Unit in Universitary Valme Hospital, Seville, Spain. She has been Director of the Universitary
Valme Hospital during 8 years. She has published more than 30 papers in reputed journals and has extensive in teaching and research experience.
Carmen Delgado Jiménez, Breast Can Curr Res 2017, 2:5 (Suppl)
DOI: 10.4172/2572-4118-C1-011